Acute pancreatitis (AP) is a common clinical emergency in the digestive system, with its global incidence showing an upward trend year by year [1]. The mortality rate in patients with severe acute pancreatitis (SAP) can reach as high as 20–30% [2,3]. And the long-term adverse outcomes of AP—including recurrent acute pancreatitis (RAP), chronic pancreatitis (CP), and post-acute pancreatitis diabetes mellitus (PPDM), continue to severely impair patients’ quality of life and increase medical burden…